Atlas Trials

Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients

Clinical trial NCT03874026 · RECRUITING

Trial details

NCT number
NCT03874026
Sponsor
National Cancer Institute, Naples
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal CancerADCC
Start date
2019-09-05
Primary completion
2023-05-19
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.